Growth Characteristics of α-Foetoprotein-Secreting Human Hepatocellular Carcinoma in Athymic (Nude) Mice
- 1 June 1983
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 64 (6) , 643-648
- https://doi.org/10.1042/cs0640643
Abstract
The growth characteristics of a human hepatocellular carcinoma, derived from the PLC/PRF/5 cell-line (''Alexander''), transplanted into sub-lethally irradiated athymic (nu/nu) mice were examined. The xenograft re-expresses .alpha.-fetoprotein production although this tumor marker was not detected during cell culture in vitro. There is a positive correlation between serum .alpha.-fetoprotein concentration and tumor mass (r = 0.978), validating the use of this tumor marker to assess growth. In mice with progressively growing xenografts there is a linear correlation between log serum .alpha.-fetoprotein concentration and time, compatible with exponential tumor growth. Growth of the human hepatocellular carcinoma xenograft is rapid, with an .alpha.-fetoprotein doubling time of 6.1 .+-. 2.1 days (.+-. SD) and a mass doubling time of 3.6 .+-. 1.2 days (.+-. SD). The tumor cell birth or production rate, determined by a stathmokinetic (metaphase arrest) technique using vincristine, is 15.7 .+-. 3.8 (95% confidence limits) cells/1000 cells per h. The tumor cell loss factor (49%) is low and may contribute to the rapid growth of this human hepatocellular carcinoma xenograft.This publication has 7 references indexed in Scilit:
- Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic miceGastroenterology, 1980
- Serum Alpha-Fetoprotein Estimations and Doubling Time in Hepatocellular Carcinoma: Influence of Therapy and Possible Value in Early DetectionJNCI Journal of the National Cancer Institute, 1980
- alpha-Fetoprotein gene expression. Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells.Journal of Biological Chemistry, 1979
- Effects of Murine Tumor Necrosis Factor on Heterotransplanted Human TumorsPathobiology, 1979
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Growth characteristics of human colorectal tumours during serial passage in immune-deprived miceBritish Journal of Cancer, 1978
- Hepatitis B surface antigen produced by a human hepatoma cell lineBritish Journal of Cancer, 1976